A January 2026 prospective cohort study found that medicinal cannabis for endometriosis pain reduced overall pelvic pain by more than 30% and improved quality-of-life scores by 46% over 12 weeks, with some patients discontinuing opioids. Dr. Benjamin Caplan reads the evidence carefully, explains what it proves and where the limits are, and frames what this means for endometriosis patients in Massachusetts.